Q4 2018 13F Holders as of 31 Dec 2018
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
22,278,088
-
Number of holders
-
158
-
Total 13F shares, excl. options
-
7,079,477
-
Shares change
-
-354,896
-
Total reported value, excl. options
-
$318,725,901
-
Value change
-
-$18,340,193
-
Put/Call ratio
-
54.74%
-
Number of buys
-
65
-
Number of sells
-
-83
-
Price
-
$45.02
Significant Holders of ANI PHARMACEUTICALS INC - Common Stock, par value $0.0001 per share (ANIP) as of Q4 2018
190 filings reported holding ANIP - ANI PHARMACEUTICALS INC - Common Stock, par value $0.0001 per share as of Q4 2018.
ANI PHARMACEUTICALS INC - Common Stock, par value $0.0001 per share (ANIP) has 158 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 7,079,477 shares
of 22,278,088 outstanding shares and own 31.78% of the company stock.
Largest 10 shareholders include BlackRock Inc. (1,368,668 shares), MANGROVE PARTNERS (549,401 shares), Vanguard Group Inc (527,560 shares), DIMENSIONAL FUND ADVISORS LP (518,427 shares), STATE STREET CORP (241,398 shares), FIRST MANHATTAN CO (234,995 shares), INVESTMENT COUNSELORS OF MARYLAND LLC (207,300 shares), RENAISSANCE TECHNOLOGIES LLC (169,400 shares), Consonance Capital Management LP (142,943 shares), and Bank of New York Mellon Corp (134,589 shares).
This table shows the top 158 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.